05/22/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
05/20/2024 3:16 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form F-1/A | |
05/20/2024 8:02 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 8:02 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 9:21 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024 3:01 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
04/12/2024 3:30 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
04/12/2024 3:30 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B5 | |
04/10/2024 8:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024 7:32 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
04/08/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
04/05/2024 8:28 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 4:10 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
04/04/2024 3:31 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
04/04/2024 3:37 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
02/22/2024 7:25 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/13/2024 12:20 PM | Gordon Ariel (Filed by) NeuroSense Therapeutics Ltd. (Subject) NeuroSense Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024 9:14 AM | Ben-Noon Alon (Filed by) NeuroSense Therapeutics Ltd. (Subject) NeuroSense Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024 8:38 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024 7:48 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024 7:49 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023 4:01 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023 4:03 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
12/21/2023 7:45 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023 3:30 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
12/14/2023 8:41 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2023 2:00 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
12/05/2023 2:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
12/05/2023 7:01 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
12/04/2023 5:17 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
11/28/2023 8:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/21/2023 9:36 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
11/13/2023 8:28 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/06/2023 7:35 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2023 7:45 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2023 8:12 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2023 10:39 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023 4:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2023 8:16 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
This Apple-like Innovator is Revolutionizing Healthcare (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
09/19/2023 8:15 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2023 8:20 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/07/2023 3:31 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
09/05/2023 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
07/21/2023 3:27 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
07/06/2023 7:30 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/05/2023 1:09 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
06/23/2023 3:05 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B5 | |
06/23/2023 3:06 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/22/2023 5:12 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B5 | |
06/13/2023 7:30 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/08/2023 8:16 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023 7:50 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |